Shopping Cart
Remove All
Your shopping cart is currently empty
Samuraciclib (CT7001) hydrochloride hydrate is a potent, selective, ATP-competitive, orally active inhibitor of CDK7 (IC50: 41 nM). It inhibits the growth of breast cancer cell lines (GI50: 0.2-0.3 μM) and exhibits potent antitumor effects.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $987 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $1,320 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $1,990 | 10-14 weeks | 10-14 weeks |
| Description | Samuraciclib (CT7001) hydrochloride hydrate is a potent, selective, ATP-competitive, orally active inhibitor of CDK7 (IC50: 41 nM). It inhibits the growth of breast cancer cell lines (GI50: 0.2-0.3 μM) and exhibits potent antitumor effects. |
| Targets&IC50 | CDK2-CyclinE1:578 nM, CDK7-CyclinH-MAT1:41 nM, CDK2:578 nM, CDK9:1.2 μM, CDK6:34 μM, CDK6:31 μM, CDK5:9.4 μM, CDK4:49 μM, CDK7:41 nM, CDK1:1.8 μM |
| Molecular Weight | 521.7 |
| Formula | C22H35ClN6O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.